S. 27 (112th): Preserve Access to Affordable Generics Act


Jan 25, 2011
112th Congress, 2011–2013

Died in a previous Congress

This bill was introduced on July 21, 2011, in a previous session of Congress, but was not enacted.


Herbert “Herb” Kohl

Senator from Wisconsin



Read Text »
Last Updated: Jul 22, 2011
Length: 18 pages

About the bill

Full Title

A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.

Summary (CRS)

7/22/2011--Reported to Senate without amendment.Preserve Access to Affordable Generics Act - Amends the Federal Trade Commission Act to authorize the Federal Trade Commission (FTC) to initiate a proceeding against parties ... Read more >

The bill’s title was written by its sponsor.


Jan 25, 2011

This is the first step in the legislative process.

Jul 21, 2011
Reported by Committee

A committee has issued a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

This is a Senate bill in the United States Congress (indicated by the “S.” in “S. 27”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.


9 cosponsors (6D, 2R, 1I) (show)
Committee Assignments

The committee chair determines whether a bill will move past the committee stage.


There have been no roll call votes related to this bill.

Related Bills

Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.

S. 369 (111th) was a previous version of this bill.

Reported by Committee
Last Action: Oct 15, 2009

Search for similar bills.

Links & tools

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.


Click a format for a citation suggestion: